A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives
| dc.contributor.author | Lazzari, Paolo | |
| dc.contributor.author | Distinto, Rita | |
| dc.contributor.author | Manca, Ilaria | |
| dc.contributor.author | Baillie, Gemma | |
| dc.contributor.author | Murineddu , Gabriele | |
| dc.contributor.author | Pira, Marilena | |
| dc.contributor.author | Falzoi, Matteo | |
| dc.contributor.author | Sani, Monica | |
| dc.contributor.author | Morales, Paula | |
| dc.contributor.author | Ross, Ruth | |
| dc.contributor.author | Zanda, Matteo | |
| dc.contributor.author | Jagerovic , Nadine | |
| dc.contributor.author | Pinna, Gerard Aime | |
| dc.contributor.institution | University of Aberdeen.Biological Sciences | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences - Cardiovascular Group | en |
| dc.date.accessioned | 2017-05-06T23:01:29Z | |
| dc.date.available | 2017-05-06T23:01:29Z | |
| dc.date.embargoedUntil | 2017-05-06 | |
| dc.date.issued | 2016-10-04 | |
| dc.description | We thank European Commission (project “PET BRAIN: Mapping the brain with PET radiolabeled cannabinoid CB1 ligands”; FP7-People-2009-IAPP; Grant Agreement N.25142). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 15 | |
| dc.format.extent | 894741 | |
| dc.identifier | 66637117 | |
| dc.identifier | c627ba0b-7b90-4a66-bd46-37e8827264ae | |
| dc.identifier | 84971349335 | |
| dc.identifier.citation | Lazzari, P, Distinto, R, Manca, I, Baillie, G, Murineddu , G, Pira, M, Falzoi, M, Sani, M, Morales, P, Ross, R, Zanda, M, Jagerovic , N & Pinna, G A 2016, 'A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives', European Journal of Medicinal Chemistry, vol. 121, pp. 194-208. https://doi.org/10.1016/j.ejmech.2016.05.011 | en |
| dc.identifier.doi | 10.1016/j.ejmech.2016.05.011 | |
| dc.identifier.issn | 0223-5234 | |
| dc.identifier.uri | http://hdl.handle.net/2164/8608 | |
| dc.identifier.vol | 121 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | European Journal of Medicinal Chemistry | en |
| dc.subject | cannabinoids | en |
| dc.subject | endocannabinoid system (ECS) | en |
| dc.subject | 8-chloro-1-(2’,4’-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide | en |
| dc.subject | cannabinoid receptor binding assays | en |
| dc.subject | CB1 receptor ligands | en |
| dc.subject | QH301 Biology | en |
| dc.subject.lcc | QH301 | en |
| dc.title | A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives | en |
| dc.type | Journal article | en |
